company background image
PBH logo

Prestige Consumer Healthcare NYSE:PBH 株式レポート

最終価格

US$71.32

時価総額

US$3.5b

7D

-2.3%

1Y

24.7%

更新

27 Sep, 2024

データ

会社財務 +

Prestige Consumer Healthcare Inc.

NYSE:PBH 株式レポート

時価総額:US$3.5b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております

PBH 株式概要

プレステージ・コンシューマー・ヘルスケア・インクは、その子会社とともに、北米、オーストラリア、および国際的な一般用医薬品(OTC)の開発、製造、販売、流通、販売を行っている。

PBH ファンダメンタル分析
スノーフレーク・スコア
評価5/6
将来の成長1/6
過去の実績3/6
財務の健全性4/6
配当金0/6

Community Narratives

Create a narrative

Narratives bring a range of perspectives from our community.

US$79.17
FV
9.9% undervalued intrinsic discount
2.21%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
19 days agoauthor updated this narrative

Prestige Consumer Healthcare Inc. 競合他社

価格と性能

の歴代最高値、変動、値下がりまとめPrestige Consumer Healthcare
過去の株価
現在の株価US$71.32
52週高値US$75.80
52週安値US$56.34
ベータ0.48
11ヶ月の変化-3.23%
3ヶ月変化3.59%
1年変化24.71%
33年間の変化28.71%
5年間の変化102.61%
IPOからの変化301.80%

最新ニュース

Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Popularity With Investors Is Under Threat From Overpricing

Sep 10
Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Popularity With Investors Is Under Threat From Overpricing

Prestige Consumer Healthcare (NYSE:PBH) Seems To Use Debt Quite Sensibly

Jul 16
Prestige Consumer Healthcare (NYSE:PBH) Seems To Use Debt Quite Sensibly

Recent updates

Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Popularity With Investors Is Under Threat From Overpricing

Sep 10
Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Popularity With Investors Is Under Threat From Overpricing

Prestige Consumer Healthcare (NYSE:PBH) Seems To Use Debt Quite Sensibly

Jul 16
Prestige Consumer Healthcare (NYSE:PBH) Seems To Use Debt Quite Sensibly

Revenues Not Telling The Story For Prestige Consumer Healthcare Inc. (NYSE:PBH)

May 22
Revenues Not Telling The Story For Prestige Consumer Healthcare Inc. (NYSE:PBH)

Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Mar 26
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

An Intrinsic Calculation For Prestige Consumer Healthcare Inc. (NYSE:PBH) Suggests It's 50% Undervalued

Mar 05
An Intrinsic Calculation For Prestige Consumer Healthcare Inc. (NYSE:PBH) Suggests It's 50% Undervalued

Prestige Consumer Healthcare Inc. (NYSE:PBH) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

Feb 11
Prestige Consumer Healthcare Inc. (NYSE:PBH) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Shares May Have Run Too Fast Too Soon

Feb 05
Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Shares May Have Run Too Fast Too Soon

Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Dec 14
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Prestige Consumer Healthcare (NYSE:PBH) Seems To Use Debt Quite Sensibly

Sep 10
Prestige Consumer Healthcare (NYSE:PBH) Seems To Use Debt Quite Sensibly

Prestige Consumer Healthcare: Unproductive Buyback And Excessive Valuation

Aug 15

Is Prestige Consumer Healthcare (NYSE:PBH) Using Too Much Debt?

Jun 12
Is Prestige Consumer Healthcare (NYSE:PBH) Using Too Much Debt?

An Intrinsic Calculation For Prestige Consumer Healthcare Inc. (NYSE:PBH) Suggests It's 43% Undervalued

May 20
An Intrinsic Calculation For Prestige Consumer Healthcare Inc. (NYSE:PBH) Suggests It's 43% Undervalued

Here's Why Prestige Consumer Healthcare (NYSE:PBH) Has Caught The Eye Of Investors

Mar 17
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Has Caught The Eye Of Investors

Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Mar 02
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Intrinsic Value Is Potentially 75% Above Its Share Price

Feb 08
Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Intrinsic Value Is Potentially 75% Above Its Share Price

Prestige Consumer Healthcare reports Q3 earnings beat; updates FY23 guidance

Feb 02

Prestige Consumer Healthcare: Taking My Winnings Off The Table

Jan 19

Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Nov 23
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Prestige Consumer Healthcare GAAP EPS of $1.02 beats by $0.02, revenue of $289.3M beats by $6.07M

Nov 03

Holding Prestige Consumer Healthcare

Aug 31

If EPS Growth Is Important To You, Prestige Consumer Healthcare (NYSE:PBH) Presents An Opportunity

Aug 26
If EPS Growth Is Important To You, Prestige Consumer Healthcare (NYSE:PBH) Presents An Opportunity

We Think Prestige Consumer Healthcare (NYSE:PBH) Can Stay On Top Of Its Debt

Aug 05
We Think Prestige Consumer Healthcare (NYSE:PBH) Can Stay On Top Of Its Debt

Prestige Consumer Healthcare GAAP EPS of $1.09 beats by $0.05, revenue of $277.1M beats by $8.18M

Aug 04

Should You Be Adding Prestige Consumer Healthcare (NYSE:PBH) To Your Watchlist Today?

May 27
Should You Be Adding Prestige Consumer Healthcare (NYSE:PBH) To Your Watchlist Today?

Is Prestige Consumer Healthcare (NYSE:PBH) A Risky Investment?

May 05
Is Prestige Consumer Healthcare (NYSE:PBH) A Risky Investment?

Does Prestige Consumer Healthcare (NYSE:PBH) Deserve A Spot On Your Watchlist?

Feb 22
Does Prestige Consumer Healthcare (NYSE:PBH) Deserve A Spot On Your Watchlist?

Is Prestige Consumer Healthcare (NYSE:PBH) A Risky Investment?

Feb 03
Is Prestige Consumer Healthcare (NYSE:PBH) A Risky Investment?

These 4 Measures Indicate That Prestige Consumer Healthcare (NYSE:PBH) Is Using Debt Extensively

Nov 04
These 4 Measures Indicate That Prestige Consumer Healthcare (NYSE:PBH) Is Using Debt Extensively

Here's Why Prestige Consumer Healthcare (NYSE:PBH) Has A Meaningful Debt Burden

Aug 06
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Has A Meaningful Debt Burden

Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Could Be 50% Below Their Intrinsic Value Estimate

Jun 14
Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Could Be 50% Below Their Intrinsic Value Estimate

株主還元

PBHUS PharmaceuticalsUS 市場
7D-2.3%-2.7%0.9%
1Y24.7%21.5%32.4%

業界別リターン: PBH過去 1 年間で22.2 % の収益を上げたUS Pharmaceuticals業界を上回りました。

リターン対市場: PBHは、過去 1 年間で30.5 % のリターンを上げたUS市場を下回りました。

価格変動

Is PBH's price volatile compared to industry and market?
PBH volatility
PBH Average Weekly Movement2.8%
Pharmaceuticals Industry Average Movement9.7%
Market Average Movement6.4%
10% most volatile stocks in US Market14.9%
10% least volatile stocks in US Market3.2%

安定した株価: PBH過去 3 か月間に大きな価格変動はありませんでした。

時間の経過による変動: PBHの 週次ボラティリティ ( 3% ) は過去 1 年間安定しています。

会社概要

設立従業員CEO(最高経営責任者ウェブサイト
1996570Ron Lombardiwww.prestigebrands.com

プレステージ・コンシューマー・ヘルスケア・インクは、その子会社とともに、北米、オーストラリア、および国際的な一般用医薬品(OTC)の開発、製造、販売、流通、販売を行っている。同社は北米OTCヘルスケアと国際OTCヘルスケアの2つのセグメントで事業を展開している。BCおよびGoody'sブランドの鎮痛パウダー、Boudreaux's Butt Pasteブランドの乳幼児用おむつかぶれ治療薬および皮膚保護剤、Chlorasepticブランドの喉の痛みや口の痛みを和らげるスプレーやトローチ、Clear Eyesブランドの充血やかゆみを和らげるアイケア製品、Compound Wブランドの一般的なイボや足底イボの家庭での除去、耳垢除去用のDebroxなどを提供している。また、DenTekブランドでデンタルガード、フロスピック、歯間ブラシ、デンタルリペア&キット、舌クリーナー、乗り物酔い止めのDramamine、Fleetブランドで浣腸やその他の下剤、胃のむかつきにGaviscon、Luden'sブランドで咳止めを提供している;女性用イースト菌感染症治療薬Monistat、シラミ・寄生虫治療薬Nix、Summer's Eveブランドの洗浄剤、クロス、スプレーなどのフェミニンケア製品、ドライアイ治療薬TheraTears、Fessブランドの鼻用生理食塩水スプレーと洗浄剤、経口補水液Hydralyteなどである。量販店、ドラッグストア、食品店、コンビニエンスストア、クラブストア、eコマースを通じて製品を販売している。同社は以前はPrestige Brands Holdings, Inc.として知られていたが、2018年8月にPrestige Consumer Healthcare Inc.に社名を変更した。プレステージ・コンシューマー・ヘルスケア・インクは1996年に設立され、ニューヨーク州タリータウンに本社を置いている。

Prestige Consumer Healthcare Inc. 基礎のまとめ

Prestige Consumer Healthcare の収益と売上を時価総額と比較するとどうか。
PBH 基礎統計学
時価総額US$3.54b
収益(TTM)US$205.13m
売上高(TTM)US$1.11b

17.2x

PER(株価収益率

3.2x

P/Sレシオ

収益と収入

最新の決算報告書(TTM)に基づく主な収益性統計
PBH 損益計算書(TTM)
収益US$1.11b
売上原価US$488.83m
売上総利益US$624.36m
その他の費用US$419.23m
収益US$205.13m

直近の収益報告

Jun 30, 2024

次回決算日

該当なし

一株当たり利益(EPS)4.14
グロス・マージン56.09%
純利益率18.43%
有利子負債/自己資本比率64.9%

PBH の長期的なパフォーマンスは?

過去の実績と比較を見る